We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$156B
AUM Growth
+$35.1B
Cap. Flow
+$26.6B
Cap. Flow %
17.03%
Top 10 Hldgs %
12%
Holding
3,631
New
339
Increased
2,078
Reduced
973
Closed
175

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$854M
2
WMT icon
Walmart Inc
WMT
+$758M
3
NVDA icon
NVIDIA
NVDA
+$464M
4
PEP icon
PepsiCo
PEP
+$462M
5
FDX icon
FedEx
FDX
+$396M

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$332M
2
ANET icon
Arista Networks
ANET
+$319M
3
DASH icon
DoorDash
DASH
+$252M
4
MNST icon
Monster Beverage
MNST
+$227M
5
COST icon
Costco
COST
+$216M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 14.8%
3 Industrials 12.12%
4 Healthcare 11.96%
5 Consumer Discretionary 11.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVGN icon
3451
Tevogen Inc. Common Stock
TVGN
$28.1M
$17.9K ﹤0.01%
456
-106
-19% -$5.21K
POWW icon
3452
Outdoor Holding Co
POWW
$269M
$17.4K ﹤0.01%
11,760
-15,803
-57% -$21.1K
PRLD icon
3453
Prelude Therapeutics
PRLD
$424M
$15.1K ﹤0.01%
10,500
-33,147
-76% -$33.2K
RVPH
3454
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$10.3K ﹤0.01%
+1,400
New +$11.9K
NMTC icon
3455
NeuroOne Medical Technologies
NMTC
$13.9M
$9.28K ﹤0.01%
1,741
-4
-0.2% -$20
IPSC icon
3456
Century Therapeutics
IPSC
$372M
$5.31K ﹤0.01%
10,660
-136,508
-93% -$73.6K
ABOS icon
3457
Acumen Pharmaceuticals
ABOS
$178M
-46,292
Closed -$53.7K
ACHV icon
3458
Achieve Life Sciences
ACHV
$695M
-25,300
Closed -$57.2K
ACRV icon
3459
Acrivon Therapeutics
ACRV
$74M
-22,252
Closed -$26.5K
ADX icon
3460
Adams Diversified Equity Fund
ADX
$3.28B
-12,151
Closed -$264K
AI icon
3461
C3.ai
AI
$1.65B
-108,932
Closed -$2.68M
AKYA
3462
DELISTED
Akoya BioSciences
AKYA
-36,409
Closed -$47.3K
AMED
3463
DELISTED
Amedisys
AMED
-33,735
Closed -$3.31M
AMPY icon
3464
Amplify Energy
AMPY
$186M
-230,989
Closed -$739K
ANSS
3465
DELISTED
Ansys
ANSS
-44,521
Closed -$15.6M
ARCT icon
3466
Arcturus Therapeutics
ARCT
$214M
-11,218
Closed -$146K
ASX icon
3467
ASE Group
ASX
$85B
-10,292
Closed -$106K
ATOS icon
3468
Atossa Therapeutics
ATOS
$23.6M
-3,222
Closed -$40.1K
AZEK
3469
DELISTED
The AZEK Co
AZEK
-219,450
Closed -$11.9M
BAER icon
3470
Bridger Aerospace
BAER
$76.5M
-39,832
Closed -$76.9K
BASE
3471
DELISTED
Couchbase
BASE
-308,180
Closed -$7.51M
BCH icon
3472
Banco de Chile
BCH
$20.7B
-101,515
Closed -$3.09M
BEKE icon
3473
KE Holdings
BEKE
$18.7B
-379,609
Closed -$6.73M
BLNK icon
3474
Blink Charging
BLNK
$85.5M
-132,791
Closed -$125K
BMEA icon
3475
Biomea Fusion
BMEA
$93.5M
-338,346
Closed -$609K

Similar funds

AQR Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, AQR Capital Management held 3,631 positions worth $156B, up 29% from $121B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

AQR Capital Management deployed $26.6B of net new capital in Q3 2025, opening 339 new positions and adding to 2,078 existing holdings. Its largest new stake was Rubrik: 1,189,403 shares worth $97.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Fortinet, an estimated $332M trimmed.

  • AQR Capital Management's largest Q3 2025 buy was Rubrik: 1,189,403 shares worth $97.8M.
  • AQR Capital Management added most to Microsoft in Q3 2025, an estimated $854M increase.
  • AQR Capital Management's biggest Q3 2025 reduction was Fortinet, cutting an estimated $332M.
  • AQR Capital Management fully exited Qfin Holdings in Q3 2025, selling an estimated $114M.
  • AQR Capital Management's ten largest holdings make up 12% of its $156B portfolio in Q3 2025.
  • AQR Capital Management opened 339 new positions and closed 175 in Q3 2025.
  • AQR Capital Management's portfolio value rose 29% quarter-over-quarter to $156B.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.